Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2008 | 02-2008 | 11-2007 | 08-2007 | 05-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 10,168 | 6,202 | 3,077 | N/A |
| Depreciation Amortization | N/A | 2,273 | 1,469 | 716 | N/A |
| Accounts receivable | N/A | 2,909 | 119 | -76 | N/A |
| Accounts payable and accrued liabilities | N/A | -2,256 | 268 | 2,845 | N/A |
| Other Working Capital | N/A | 1,645 | -4,036 | -1,414 | N/A |
| Other Operating Activity | 0 | -3,290 | -1,878 | -2,324 | 0 |
| Operating Cash Flow | $N/A | $11,449 | $2,144 | $2,824 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2,364 | -1,458 | -236 | N/A |
| Net Acquisitions | N/A | -86 | -29 | N/A | N/A |
| Other Investing Activity | 0 | 106 | 107 | -4 | 0 |
| Investing Cash Flow | $N/A | $-2,344 | $-1,380 | $-240 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 232 | N/A |
| Debt Repayment | N/A | N/A | N/A | -5 | N/A |
| Common Stock Issued | N/A | 1,120 | 781 | 570 | N/A |
| Common Stock Repurchased | N/A | -20,837 | -20,837 | -20,596 | N/A |
| Other Financing Activity | 0 | 3,321 | 1,866 | 909 | 0 |
| Financing Cash Flow | $N/A | $-16,396 | $-18,190 | $-18,890 | $N/A |
| Beginning Cash Position | N/A | 62,556 | 62,556 | 62,556 | N/A |
| End Cash Position | N/A | 55,265 | 45,130 | 46,250 | N/A |
| Net Cash Flow | $N/A | $-7,291 | $-17,426 | $-16,306 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 11,449 | 2,144 | 2,824 | N/A |
| Capital Expenditure | N/A | -2,364 | -1,458 | -236 | N/A |
| Free Cash Flow | 0 | 9,085 | 686 | 2,588 | 0 |